Ligand profile
ZINC146373408
Virtual-screening candidate from ZINC.
Bound to: VK055_1539 — 3-deoxy-D-manno-octulosonate cytidylyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC146373408- UniProt (similar protein)
P44490- Tanimoto
- 0.577
- Target protein
- VK055_1539
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 166.4
- −1 ≤ LogP ≤ 5 -1.79
- MW ≤ 500 Da 337.2
- LogP ≤ 5 -1.79
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 166.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CO[P@](=O)(O)OC[C@@H]1O[C@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1OCO[P@](=O)(O)OC[C@@H]1O[C@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O
InChI=1S/C10H16N3O8P/c1-19-22(17,18)20-4-5-7(14)8(15)9(21-5)13-3-2-6(11)12-10(13)16/h2-3,5,7-9,14-15H,4H2,1H3,(H,17,18)(H2,11,12,16)/t5-,7+,8+,9-/m0/s1InChI=1S/C10H16N3O8P/c1-19-22(17,18)20-4-5-7(14)8(15)9(21-5)13-3-2-6(11)12-10(13)16/h2-3,5,7-9,14-15H,4H2,1H3,(H,17,18)(H2,11,12,16)/t5-,7+,8+,9-/m0/s1
SBNCJYVJGQRGNM-HKVUECMASA-NSBNCJYVJGQRGNM-HKVUECMASA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CMK
- Homolog
- P44490
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC146373408 →
- ZINC ZINC20 ZINC146373408 →
- UniProt UniProt P44490 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC146373408”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1539.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).